| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 3 Jul 2026 | 30 Jun 2026 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/07/2026 inter alia to consider and approve 1. To consider and approve to Sub- Division (Split) of the Equity Shares of the Company subject to the approval of the Shareholders and such authorities as may be required and; 2. To consider any other matters with the permission of the Board. | ||
| Board Meeting | 29 Jun 2026 | 29 Jun 2026 |
| Pursuant to the Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of Integrated Proteins Limited at their meeting held today, Monday, June 29,2026 inter alia, approved: 1. Resignation of Mr.Karanj Dharmeshbhai Doshi (DIN: 10848249 ) as Managing Director of the Company | ||
| Board Meeting | 30 May 2026 | 30 May 2026 |
| Pursuant to Regulation 30 and Schedule III SEBI(LODR), we hereby inform of the resignation of the Company Secretary and appointment of a new Company Secretary. | ||
| Board Meeting | 26 May 2026 | 20 May 2026 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve Audited Standalone Financial results for the quarter and year ended March 31, 2026. Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve the Standalone Audited Financial Results of the Company for the quarter and year ended March 31, 2026 (As per BSE Announcement dated on: 25.05.2026) The Board has considered and approved the financials for the Quarter and year ended March 31,2026. (As Per BSE Announcement Dated on 26.05.2026). Revised outcome for the Quarter and Year ended March 31,2026.. (As per BSE announcement dated on : 27.05.2026) | ||
| Board Meeting | 12 Feb 2026 | 7 Feb 2026 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve meeting of the board of directors of company is scheduled on Thursday 12th February 2026; interalia to approve the unaudited financial results for the quarter and nine months ended on 31st December 2025 together with the Limited Review Report for the said period and to discuss any other item as tabled. Pursuant to the provisions of Regulation 30 (read with Part A of Schedule IIf) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), and in continuation to our letter dated 7th February, 2026, we hereby report the outcome of the meeting of the Board of Directors held today, ie: Thursday, 12th February, 2026, inter-alia, to consider and approve the following: 1. Considered and approved the Unaudited Financial Results for the Quarter and Nine Months ended on 31 December, 2025 along with the Limited Review Report by the auditors. 2. Reviewed business of the Company. The Board meeting commenced at 04:30 PM and ended at 05:00 PM. You are requested (As Per BSE Announcement Dated on: 12/02/2026) | ||
| Board Meeting | 30 Dec 2025 | 30 Dec 2025 |
| Pursuant to Regulation 30 and Schedule III SEBI(LODR) we hereby inform of the resignation of the company secretary and appointment of a new company secretary. | ||
| Board Meeting | 7 Nov 2025 | 4 Nov 2025 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve Pursuant to regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform you that the Meeting of the Board of Directors of the Company will be held on Friday 07th November 2025 inter alia where along with other matters the Board shall consider and approve the Standalone Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025. Approval of Unaudited results for the quarter and half year ender 30th September, 2025 for the FY 2025-26 Pursuant to the provisions of Regulation 30 (read with Part A of Schedule III) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), and in continuation to our letter dated 04th November 2025, we hereby report the outcome of the meeting of the Board of Directors held today, i.e. Friday, 07th November, 2025, inter-alia, to consider and approve the following: 1. Considered and approved the unaudited financial results for the quarter ended 30th September, 2025 together with the Limited Review Report by the Auditors. (As Per BSE Announcement Dated on:07.11.2025) | ||
| Board Meeting | 28 Aug 2025 | 28 Aug 2025 |
| Outcome of Board Meeting and Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for appointment of an independent director having DIN - 11255979 and cessation of an independent director having DIN - 01478375 and other matters Outcome of the Board meeting and Disclosure under Regulation 30 of SEBI(LODR), Regulation 2015 for appointment of Independent Director having DIN 11255979 and Retirement of an Independent Director having DIN 01478375 and other matters. (As Per BSE Announcement Dated on:29.08.2025) | ||
| Board Meeting | 14 Aug 2025 | 8 Aug 2025 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Prior Intimation of Board Meeting and Trading Window Regulation 29 (1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 Outcome of Board Meeting pursuant to Regulation 30, 32 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (SEBI LODR) (As Per BSE Announcement Dated on: 14.08.2025) | ||
| Board Meeting | 7 Aug 2025 | 31 Jul 2025 |
| Integrated Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve Intimation of Board Meeting under Regulation 29 of SEBI (LODR) Regulations 2015. Outcome of Board Meeting held today i.e., August 7, 2025 (As per BSE Announcement Dated on 07/08/2025) | ||
| Board Meeting | 1 Aug 2025 | 1 Aug 2025 |
| Outcome of Board Meeting held today i.e., August 1, 2025 | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
